As part of a plan to double its GDP and create more job opportunities, the Isle of Man is looking to grow and export cannabis products for medical use.
Near Ireland and the United Kingdom (UK), where cannabis is illegal except for medical purposes, the Isle of Man is home to 84,000 citizens and an economy driven mostly by the insurance sector (1,2). Now, as part of a plan to diversify its economy, grow its population by 100,000 over the next 15 years, and create 5,000 more jobs, the island hopes to license up to 10 firms by the end of 2025 to grow and sell cannabis products for medical use (1).
“As a high-value, low-volume manufacturing business it fits well into what we need to do on the island. We need to make sure when things are exported they are high value,” said Tim Johnston, the Isle of Man’s minister for enterprise (1). “We recognize we’ve got an older population. We’re keen to see that change,” he also stated.
Competition for the Isle of Man includes several other UK producers that already have approval to sell medical cannabis oil and products, plus two other islands, Jersey and Guernsey, that have already legalized medical cannabis cultivation (1). All UK companies selling medical cannabis must meet strict requirements, and only specialist doctors can prescribe cannabis for medical uses (1).
Last year the first conditional license on the Isle of Man was issued to GrowLab Organics, a British cannabis company headquartered on the island (1,3). It has applied to build a growing facility and hopes to export 15 tons of cannabis per year from the island (1).
References
Collaboration, Gender Diversity, and Progress: Julie Kowalski on Advancing Cannabis Science
December 10th 2024In this interview with Cannabis Science and Technology, Julie Kowalski, an experienced analytical chemist, discusses her path into the cannabis industry, starting with early work in gas chromatography. Kowalski reflects on her perspectives as a female scientist, highlighting biases she’s experienced and the benefits of gender inclusivity in the cannabis space. Greater unity and professionalism could benefit the industry as a whole, she explains. She also encourages collaboration and more women in leadership positions in order to build a stronger scientific community, and also urges women to advocate for themselves, noting that women in cannabis face unique obstacles but often demonstrate consensus-building strategies and solutions.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Gender Diversity and Innovation in the Cannabis Space: Insights from Tess Eidem, PhD
December 9th 2024Cannabis Science and Technology sat down with Tess Eidem, PhD, PCQI, member of Saturn Scientific, LLC, to discuss her journey from antibiotic research to cannabis microbiology and her observations throughout her career. Dr. Eidem highlights challenges women face in this male-dominated industry, including limited representation in leadership roles and frequent experiences of bias and discrimination. She emphasizes the importance of gender diversity in fostering innovation, improving product safety, and addressing women’s health needs in cannabis applications. Her advice to women scientists is to build strong professional relationships and carefully evaluate work environments to advance their careers in this evolving and often challenging space.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.